Enabling Diversity & Inclusion In Clinical Trials: A CRO & IRB Perspective

In the first webinar in the series, Amanda Ryan, President of G3 Life Sciences, will speak with Aman Khera, VP, Global Head of Regulatory Strategy at Worldwide Clinical Trials, and Luke Gelinas, Advarra’s IRB Chair and Senior Advisor, about their perspective on diversity in clinical trials. They will discuss the role language services and cultural competency play in creating greater access to information for patients, as well as how more robust payment practices and decentralized clinical trials can further diversify the patient population.